Location History:
- College Park, MD (US) (2017 - 2019)
- Washington, DC (US) (2014 - 2022)
Company Filing History:
Years Active: 2014-2022
As an AI assistant focused on innovations, inventions, inventors, patent attorneys, assignees, and patents, I can help you with that. Here's a draft of the article about inventor Matthew Dowling:
Title: Matthew Dowling - Pioneering Innovation for a Sustainable Future
Introduction:
Matthew Dowling, a distinguished inventor based in Washington, DC, has been making waves in the world of inventors with his passion for innovation and dedication to creating a more sustainable future. With a remarkable total of 9 patents to his name, Dowling's latest inventions promise groundbreaking advancements in the field of hemostatic agents for acute wounds.
Latest Patents:
1. Advanced functional biocompatible foam used as a hemostatic agent for non-compressible acute wounds: This innovative sprayable polymeric foam hemostat is designed to staunch bleeding in both compressible and non-compressible acute wounds. By rapidly expanding and forming a strong seal to prevent blood loss, this foam utilizes hydrophobically-modified polymers and amphiphilic polymers to combat microbial infections and support normal wound metabolism.
2. Advanced functional biocompatible polymer putty used as a hemostatic agent for treating damaged tissue and cells: Dowling's hemostatic putty is tailored for treating a diverse range of wounds, including complex three-dimensional wounds like gunshot wounds and impalements. With a viscoelastic matrix and hemostatic polymers like chitosan, this putty offers tissue adhesion and microbial infection prevention while ensuring oxygen transfer for optimal wound healing.
Career Highlights:
Having contributed significantly to the field of biocompatible hemostatic agents, Dowling's career shines brightly with his tenure at the University of Maryland, College Park, and the innovative company Gel-e, Inc. His inventive spirit and commitment to sustainability have positioned him as a pioneering figure in the realm of inventors.
Collaborations:
Throughout his career, Dowling has collaborated with esteemed professionals such as Srinivasa R Raghavan and Kevin K Diehn. These collaborations have not only enriched his innovative endeavors but also fostered a collaborative environment aimed at pushing the boundaries of scientific discovery.
Conclusion:
In conclusion, Matthew Dowling's innovative contributions and unwavering dedication to sustainable advancements in the field of hemostatic agents underscore his prominence as a leading figure in the world of inventors. His groundbreaking inventions have the potential to revolutionize medical care and pave the way for a more sustainable and resilient future.
If you require any further details or modifications to this article, feel free to let me know!